Study to Evaluate LB-LR1109 for the Treatment of Solid Tumors

Conditions: Non-small Cell Lung Cancer(NSCLC); Head and Neck Squamous Cell Carcinoma(HNSCC); Renal Cell Carcinoma(RCC); Urothelial Carcinoma; Malignant Melanoma Interventions: Drug: LB-LR1109 Sponsors: LG Chem Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials